First Trust Advisors LP increased its holdings in Stericycle Inc (NASDAQ:SRCL) by 169.3% in the second quarter, HoldingsChannel reports. The firm owned 19,323 shares of the business services provider’s stock after acquiring an additional 12,149 shares during the period. First Trust Advisors LP’s holdings in Stericycle were worth $1,262,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its position in Stericycle by 8.3% during the 2nd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 45,631 shares of the business services provider’s stock valued at $2,979,000 after buying an additional 3,500 shares during the period. Wells Fargo & Company MN boosted its position in Stericycle by 10.9% during the 2nd quarter. Wells Fargo & Company MN now owns 3,345,764 shares of the business services provider’s stock valued at $218,445,000 after buying an additional 329,741 shares during the period. Exchange Capital Management Inc. boosted its position in Stericycle by 4.5% during the 2nd quarter. Exchange Capital Management Inc. now owns 47,610 shares of the business services provider’s stock valued at $3,108,000 after buying an additional 2,035 shares during the period. Cognios Beta Neutral Large Cap Fund LP purchased a new stake in Stericycle during the 2nd quarter valued at $2,550,000. Finally, Sumitomo Mitsui Trust Holdings Inc. boosted its position in Stericycle by 5.4% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 249,109 shares of the business services provider’s stock valued at $16,264,000 after buying an additional 12,753 shares during the period. 95.46% of the stock is owned by institutional investors.

Shares of SRCL opened at $61.87 on Monday. The company has a debt-to-equity ratio of 0.87, a current ratio of 0.81 and a quick ratio of 0.81. Stericycle Inc has a twelve month low of $56.64 and a twelve month high of $76.73. The firm has a market cap of $5.26 billion, a price-to-earnings ratio of 14.26, a PEG ratio of 1.42 and a beta of 0.36.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, August 2nd. The business services provider reported $1.17 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.13 by $0.04. Stericycle had a net margin of 5.03% and a return on equity of 14.04%. The business had revenue of $883.30 million during the quarter, compared to analyst estimates of $896.62 million. During the same period in the prior year, the business earned $1.15 EPS. The company’s revenue for the quarter was down 3.7% on a year-over-year basis. equities research analysts forecast that Stericycle Inc will post 4.47 EPS for the current fiscal year.

In other Stericycle news, CFO Daniel Ginnetti sold 5,000 shares of the company’s stock in a transaction on Friday, July 27th. The shares were sold at an average price of $70.75, for a total value of $353,750.00. Following the completion of the transaction, the chief financial officer now directly owns 11,490 shares in the company, valued at approximately $812,917.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark C. Miller sold 95,227 shares of the company’s stock in a transaction on Monday, July 2nd. The stock was sold at an average price of $65.05, for a total transaction of $6,194,516.35. Following the completion of the transaction, the director now owns 257,488 shares of the company’s stock, valued at $16,749,594.40. The disclosure for this sale can be found here. Insiders sold a total of 170,601 shares of company stock valued at $11,153,063 over the last 90 days. Company insiders own 3.50% of the company’s stock.

SRCL has been the subject of several analyst reports. Jefferies Financial Group set a $75.00 price target on shares of Stericycle and gave the company a “buy” rating in a research report on Thursday, August 2nd. Zacks Investment Research raised shares of Stericycle from a “hold” rating to a “buy” rating and set a $73.00 price target for the company in a research report on Friday, July 6th. BidaskClub raised shares of Stericycle from a “hold” rating to a “buy” rating in a research report on Tuesday, July 3rd. Barrington Research reissued a “buy” rating on shares of Stericycle in a research report on Friday, June 1st. Finally, BMO Capital Markets reissued a “hold” rating and set a $71.00 price target on shares of Stericycle in a research report on Thursday, July 12th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. Stericycle currently has a consensus rating of “Hold” and an average target price of $71.71.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.

See Also: Earnings Per Share (EPS) Explained

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.